Clinical Trial Update: Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin

View source ↗

Summary

A completed pharmacogenomic study at Samsung Medical Center aims to predict oxaliplatin-induced neurotoxicity in patients with curatively resected stage III col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Curatively Resected Stage III Colon Cancer | Status: COMPLETED